INCIDAVI: Violence Sexual Incidence During the First Year of Residence on Asylum Seekers

Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05007431
Collaborator
(none)
360
5

Study Details

Study Description

Brief Summary

Asylum seekers women are particularly exposed to sexual violence. One in seven women in France and one in three in the world say they have been a victim of sexual violence at least once in her life.

The main objective of this study is to measure the incidence of sexual violence suffered by women in asylum proceedings during their first year of stay on French territory, in Marseille and Nice.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaires

Detailed Description

Introduction: One in seven women in France and one in three in the world say they have been a victim of sexual violence at least once in his life. They are exacerbated in vulnerable populations, marginalized, in post-conflict situations or population displacement.

Therefore asylum seekers women are particularly exposed to sexual violence. This is why OFPRA and the Ministry of Solidarity and Health have protected these women with regard to sexual violence, one of the priority issues for public health. Yet, the investigators do not know the proportion of women seeking asylum who have suffered violence on French soil. In addition, the investigators did not find an international study of the incidence of violence sexual abuse suffered in the host country by women seeking asylum. Objective: Determine the incidence of sexual violence that occurred in the year following the arrival on French soil of adult women in the asylum process in Marseille and Nice.

Methodology: Multicentric longitudinal observational study (Marseille and Nice) based on a historical cohort of sexual violence among women in the application process asylum. 1,800 adult women seeking asylum were registered in 2019 in Marseille and Nice. The number of subjects required is 450 women (1: 4 sample of the target population).

Data collection will be carried out by hetero-questionnaire carried out in the presence of the questioned.

Study Design

Study Type:
Observational
Anticipated Enrollment :
360 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Violence Sexual Incidence During the First Year of Residence in the French Territory on Asylum Seekers in Marseille and Nice
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Women asylum seekers

Other: Questionnaires
Data collection will be carried out by hetero-questionnaire carried out in the presence of the questioned.

Outcome Measures

Primary Outcome Measures

  1. Questionnaires on sexual violence suffered v1.1 [6 months]

    The incidence of any of the following four events: rape or attempted rape or sexual assault or sexual exhibition that occurred on French soil during the first year of residence in France with women in the asylum procedure in France, defined by at least one positive response on the questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age> 18 years old

  • Major arrival (> 18 years old) on French territory

  • In the asylum application procedure with the GUDA in Marseille or Nice

  • Having a decline of residence on French soil of twelve months over the last 2 years.

  • No objection to participating in the study

Exclusion Criteria:
  • Existence of cognitive disorders (dementia, mental retardation) limiting the collection of criteria for judgment

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assistance Publique Hopitaux De Marseille

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT05007431
Other Study ID Numbers:
  • 2021-05
First Posted:
Aug 16, 2021
Last Update Posted:
Aug 16, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 16, 2021